Policy Brief
Published on 15 Apr 2022
Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.864960
- 11,597 views
- 9 citations
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
518 articles
articles
Original Research
Published on 30 Mar 2022
Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.869262
- 3,497 views
- 2 citations
Original Research
Published on 28 Mar 2022
Medication Errors and Type 2 Diabetes Management: A Qualitative Exploration of Physicians' Perceptions, Experiences and Expectations From Quetta City, Pakistan
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.846530
- 5,680 views
- 6 citations
Perspective
Published on 22 Mar 2022
Bioethics and COVID-19: Considering the Social Determinants of Health
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.824791
- 5,327 views
- 4 citations
Original Research
Published on 09 Mar 2022
Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.820755
- 15,576 views
- 33 citations
Original Research
Published on 02 Mar 2022
The Pivotal Role of Quality Technical Structures for Clinical Trials Oversight in the Achievement of Long-Term Capacity Strengthening Outcomes
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.772605
- 3,373 views
- 2 citations
Brief Research Report
Published on 02 Mar 2022
An Infodemic of Misinformation on Stem Cell Therapy Among the Population of Saudi Arabia: A Cross-Sectional Study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.789695
- 5,769 views
- 8 citations
Original Research
Published on 25 Feb 2022
Panic, Psycho-Behavioral Responses, and Risk Perception in the Earliest Stage of the COVID-19 Pandemic in China
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.766842
- 3,189 views
- 6 citations
Perspective
Published on 18 Feb 2022
Establishing a Public Resource for Acceptable Surrogate Endpoints to Support FDA Marketing Applications
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.820990
- 4,658 views
- 6 citations
Original Research
Published on 17 Feb 2022
Orphan Drug Prices and Epidemiology of Rare Diseases: A Cross-Sectional Study in Italy in the Years 2014–2019
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.820757
- 10,948 views
- 15 citations
Study Protocol
Published on 15 Feb 2022
A Protocol of a Guideline to Establish the Evidence Ecosystem of Acupuncture
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.711197
- 4,902 views
- 12 citations
Original Research
Published on 08 Feb 2022
Process Evaluation of a Randomised Controlled Trial for TeleClinical Care, a Smartphone-App Based Model of Care
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.780882
- 9,072 views
- 12 citations
Policy and Practice Reviews
Published on 03 Feb 2022
Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.818647
- 9,588 views
- 14 citations
Policy and Practice Reviews
Published on 02 Feb 2022
COVID-19 Compulsory Vaccination: Legal and Bioethical Controversies
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.821522
- 19,998 views
- 19 citations
Review
Published on 24 Jan 2022
Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.788777
- 8,150 views
- 37 citations
Original Research
Published on 20 Jan 2022
The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.811855
- 23,576 views
- 39 citations
Perspective
Published on 13 Jan 2022
The Current Status and Future Direction of Clinical Research in Japan From a Regulatory Perspective
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.816921
- 13,599 views
- 11 citations
Original Research
Published on 13 Jan 2022
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.817678
- 3,029 views
- 3 citations
Perspective
Published on 12 Jan 2022
Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.820335
- 11,327 views
- 21 citations
Review
Published on 11 Jan 2022
Management of Medico-Legal Risks in Digital Health Era: A Scoping Review
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.821756
- 17,721 views
- 66 citations
Perspective
Published on 10 Jan 2022
Repurposing of Medicines in the EU: Launch of a Pilot Framework
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.817663
- 8,342 views
- 18 citations
Original Research
Published on 24 Dec 2021
COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.812370
- 12,426 views
- 17 citations
Original Research
Published on 23 Dec 2021
The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.795659
- 4,526 views
- 4 citations
Original Research
Published on 20 Dec 2021
Medication Errors in Secondary Care Hospitals in Kuwait: The Perspectives of Healthcare Professionals
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.784315
- 7,243 views
- 10 citations